Zimmer Biomet Holdings Inc (NYSE: ZBH): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Zimmer Biomet Receives FDA Clearance for ROSA® Shoulder System – the World’s First Robotic Assistant for Shoulder Replacement Surgery.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

ZBH belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. The current market capitalization of Zimmer Biomet Holdings Inc is $27.07B. A total of 1.43 million shares were traded on the day, compared to an average of 1.54M shares.

In the most recent transaction, Yi Sang sold 1,705 shares of ZBH for 126.86 per share on Mar 07 ’24. After the transaction, the Group President, Asia Pacific now owns 18,179 company shares. In a previous transaction on Feb 22 ’24, Phipps Chad F sold 26,156 shares at 128.62 per share. ZBH shares that Sr. VP/Gen Counsel/Secretary owns now total 44,145.

Among the insiders who bought shares, Jafry Syed A. acquired of 2,135 shares on Nov 09 ’23 at a per-share price of $104.75. This resulted in the Director holding 4,060 shares of ZBH after the transaction. In another insider transaction, Kolli Sreelakshmi bought 1,000 shares at $120.37 per share on Aug 30 ’23. Company shares held by the Director now total 1,000.

Dividend

Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Zimmer Biomet Holdings Inc pays an annual dividend of $1.20, resulting in a dividend yield of 0.91%, and it has a price to earnings (P/E) ratio of 27.00. ZBH’s most recent ex-dividend date was 3/27/2024 when it declared a $0.24 quarterly dividend that was paid in cash on 4/30/2024. Previously, the company paid the dividend on 1/31/2024 with an ex-dividend date of 12/26/2023. The ZBH stock dividend was $0.24 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ZBH has a high of $149.25 and a low of $102.00.

As of this writing, ZBH has an earnings estimate of $1.87 per share for the current quarter. EPS was calculated based on a consensus of 24 estimates, with a high estimate of $1.96 per share and a lower estimate of $1.8. The company reported an EPS of $1.65 in the last quarter, which was 3.10% higher than expectations of $1.6.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ZBH’s latest balance sheet shows that the firm has $378.10M in Cash & Short Term Investments as of fiscal 2021. There were $7.08B in debt and $3.47B in liabilities at the time. Its Book Value Per Share was $60.70, while its Total Shareholder’s Equity was $12.67B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZBH is Buy with a score of 3.48.

Most Popular

Related Posts